The prestigious urologists Manoj Monga of the Cleveland Clinic and Olivier Traxer of the Sorbonne and Pierre and Marie Curie University are organising the first The Talents (The Trans-Atlantic Leaders in Endourological Technologies) symposium, from 5 to 7 April in Paris, in order to build bridges between young European and North American leaders in the field of endourology.
The 33rd European Urology Congress (EAU 2018) closed its doors yesterday in Copenhagen with excellent figures: 15,000 urologists, 160 companies and 2,000 business representatives. Devicare has been present in the exhibition area together with one of its international partners presenting Lit-Control®, the first medical solution which allows recurrent urinary diseases to be effectively addressed with an innovative solution enabling patients to check their own urinary pH with remote monitoring.
Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.
Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.
LELR-AEU 2018 Meeting report Advances in the treatment and medical management of lithiasis, which affects 15% of Spain’s population and is increasing considerably, namely renal lithiasis, were the focus of the 28th National Meeting of the Groups of Lithiasis, Endourology, Laparoscopy and Robotics organized by the Spanish Association of Urology on January 25 and 26 in Cordoba.
Devicare has signed a participative loan worth 2 million Euros from the Innova Global line by Avançsa, assigned to the Business and Expertise Department, with the option to convert the investment into Series A stock in the mid-term. With this new economic injection, Devicare will continue the strategic development and validation plan of new medical solutions under the Remote Patient Monitoring concept...
Devicare has been one of the companies invited to the Lessons Learned held by the CataloniaBio and Biocat business association on 29 November in Barcelona to explain its business strategy and the lessons it has learned since it was founded in 2012. The debate centred on the convergence between the biopharmaceutical and MedTech sectors to contribute innovative and effective solutions to the world's most prominent diseases.
The Cerdanyola Empresarial gala took place yesterday in the Hotel of the Autonomous University of Barcelona, where Devicare collected the Prize for Research and innovation 2017 for its work in developing medical devices and solutions and remote patient monitoring. Rosendo Garganta, founder and CEO of Devicare, received the award from the president of the Entrepreneurs Association Lluís Sisquella.
Barcelona's Hospital Delfos will implement a healthcare improvement plan based on home-based self-monitoring for patients to reduce the recurrence of chronic urological diseases such as renal and urinary lithiasis (kidney or bladder stones) and urinary infections, among others. This will also help strengthen patients' proactive participation in the clinical decisions that directly affect them.
34.3% of Catalans suffer from a chronic disease. Mental disorders are one of the most prevalent diseases and also have a major functional impact on the individuals. Individuals who suffer mental illnesses need frequent check-ups to optimize treatment, prevent relapses and improve adherence.
Board Member and Private Investor in different biotech start-ups.
Former President of Medical Devices Committee at Catalonia Association of Biotech Companies.
Master in Business Administration.
Master in International Business.
Master in Entrepreneurship & Innovation.
BSc. Industrial Engineering.
BSc. Electronic Engineering.
+10 years of experience in Business Development in MD companies.
QMS Manager at Mesoestetic.
Deputy Quality Manager at SANJO.
PDD at IESE.
Master in Business Administration.
BSc in Chemical Engineering.
+15 years of experience managing QA and QC in different industrial companies (pharma and automotive sectors)
Marketing Director at Rubió.
Marketing Director at Lacer.
Master in Business Administration.
BSc in Law.
+25 years in strategic marketing positions managing budgets +€20 M, sales force +300 representatives, and having launched +10 products to the market in Urology and Cardiology.
+15 Years of experience in strategic positions regarding prototype and production in prestigious companies as Sanyo or Ateknea. Master’s in production management. BSc Electronic Engineering.
Scientific Director at AB-Biotics
PhD in Microbiology
BSc in Food Science and Technology
BSc in Biology
+15 years of experience in strategic research positions managing the development of innovative nutraceuticals and monitoring clinical trials
Financial Director at Medichem.
Financial Director at Combino.
Master in Financial Management.
BSc in Business Administration.
+20 years of experience in strategic financial positions managing budgets of +€80 M, investments of +€50 M and being in charge of the M&A of Combino by Medichem Group.
System Manager at Ficosa.
R&D Manager at FTE Maximal.
R&D Manager at SANYO.
Master in Project Management.
BSc in Telecom. Engineering.
+20 years of experience in strategic R&D positions managing the development of successful products and creating R&D teams from scratch to +120 people.